These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22944320)

  • 1. Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tsugane S; Takizawa S; Kaneyama T; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2012 Nov; 252(1-2):66-74. PubMed ID: 22944320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takeichi N; Yanagisawa S; Kaneyama T; Yagita H; Jin YH; Kim BS; Koh CS
    Int Immunol; 2010 Sep; 22(9):729-38. PubMed ID: 20685674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tomiki H; Kaneyama T; Kobayashi K; Inaba Y; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Mar; 268(1-2):25-34. PubMed ID: 24434077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Yanagisawa S; Takeichi N; Kaneyama T; Yagita H; Taniguchi S; Kim BS; Koh CS
    Brain Res; 2010 Mar; 1317():236-45. PubMed ID: 20045400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody.
    Inoue A; Koh CS; Yamazaki M; Yahikozawa H; Ichikawa M; Yagita H; Kim BS
    J Immunol; 1998 Nov; 161(10):5586-93. PubMed ID: 9820536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Iwahashi T; Inoue A; Koh CS; Shin TK; Kim BS
    Cell Immunol; 1999 Jun; 194(2):186-93. PubMed ID: 10383821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anti-B7-1 and anti-B7-2 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Yagita H
    J Immunol; 1999 Dec; 163(11):6180-6. PubMed ID: 10570309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
    Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
    Palma JP; Yauch RL; Lang S; Kim BS
    J Immunol; 1999 Jun; 162(11):6543-51. PubMed ID: 10352270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG; Karpus WJ; VanderLugt C; Miller SD
    J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease.
    Kang MH; Jin YH; Kim BS
    Front Cell Infect Microbiol; 2018; 8():9. PubMed ID: 29410948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).
    Hirano Y; Kobayashi K; Tomiki H; Inaba Y; Ichikawa M; Kim BS; Koh CS
    Int Immunol; 2016 Dec; 28(12):575-584. PubMed ID: 27803063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Ichikawa M; Isobe M; Ishihara Y; Yagita H; Kim BS
    Int Immunol; 1997 Dec; 9(12):1837-47. PubMed ID: 9466311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
    Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pentoxifylline (PTX) on Theiler's murine encephalomyelitis (TMEV)-induced demyelinating disease.
    Fushimi T; Inoue A; Koh CS; Yamazaki M; Ishihara Y; Kim BS
    Cell Immunol; 1998 Jun; 186(2):140-6. PubMed ID: 9665756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Koh C; Inoue A; Yamazaki M; Kim BS
    J Neuroimmunol; 2000 Aug; 108(1-2):22-8. PubMed ID: 10900333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.